Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial by Tameris, MD, Hatherill, M, Landry, B, Scriba, T, Snowden, M, Lockhart, S, Lockhart, S, Shea, J, McClain, J, Hussey, G, Hussey, G, Hanekom, W, Mahomed, H, Mahomed, H, McShane, H

P16-05. Upregulation of PD-1 and CTLA-4 on HIV-specific T cells in HIV-infected infants by Hanekom W, Hussey G, Hughes J, de Kock M, Mansoor N, Day C, Nqoko BS

Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth by Fletcher, H, Keyser, A, Bowmaker, M, Sayles, P, Kaplan, G, Hussey, G, Hill, A, Hanekom, W

The role of clinical symptoms in the diagnosis of intrathoracic tuberculosis in young children by Mcshane, H, Tameris, M, Luabeya, K, Geldenhuys, H, Scriba, T, Hussey, G, Mahomed, H, Landry, B, Hanekom, W, Hatherill, M

The global epidemiology of viral-induced acute liver failure: a systematic review protocol by Patterson, J, Hussey, H, Abdullahi, L, Silal, S, Goddard, L, Setshedi, M, Spearman, W, Hussey, G, Kagina, B, Muloiwa, R

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. by Tameris, MD, Hatherill, M, Landry, B, Scriba, T, Snowden, M, Lockhart, S, Shea, J, McClain, J, Hussey, G, Hanekom, W, Mahomed, H, McShane, H

Risk of disease after isoniazid preventive therapy for mycobacterium tuberculosis exposure in young HIV uninfected children by Mcshane, H, Tameris, M, Luabeya, K, Geldenhuys, H, Scriba, T, Hussey, G, Mahomed, H, Landry, B, Hanekom, W, Hatherill, M, Toefey, A, Hughes, E, Van Schalkwyk, A

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. by Hawkridge, T, Scriba, T, Gelderbloem, S, Smit, E, Tameris, M, Moyo, S, Lang, T, Veldsman, A, Hatherill, M, Merwe, L, Fletcher, H, Mahomed, H, Hill, A, Hanekom, W, Hussey, G, Mcshane, H

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study by Fletcher, H, Filali-Mouhim, A, Nemes, E, Hawkridge, A, Keyser, A, Njikan, S, Hatherill, M, Scriba, T, Abel, B, Kagina, B, Veldsman, A, Agudelo, N, Kaplan, G, Hussey, G, Sekaly, R, Hanekom, W, BCG study team

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, van der Merwe, L, de Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, Van Der Merwe, L, De Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. by Scriba, T, Tameris, M, Mansoor, N, Smit, E, van der Merwe, L, Isaacs, F, Keyser, A, Moyo, S, Brittain, N, Lawrie, A, Gelderbloem, S, Veldsman, A, Hatherill, M, Hawkridge, A, Hill, A, Hussey, G, Mahomed, H, Mcshane, H, Hanekom, W

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. by Scriba, T, Tameris, M, Mansoor, N, Smit, E, van der Merwe, L, Mauff, K, Hughes, E, Moyo, S, Brittain, N, Lawrie, A, Mulenga, H, de Kock, M, Gelderbloem, S, Veldsman, A, Hatherill, M, Geldenhuys, H, Hill, A, Hussey, G, Mahomed, H, Hanekom, W, Mcshane, H

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. by Scriba, T, Tameris, M, Smit, E, van der Merwe, L, Hughes, E, Kadira, B, Mauff, K, Moyo, S, Brittain, N, Lawrie, A, Mulenga, H, de Kock, M, Makhethe, L, Janse van Rensburg, E, Gelderbloem, S, Veldsman, A, Hatherill, M, Geldenhuys, H, Hill, A, Hawkridge, A, Hussey, G, Hanekom, W, McShane, H, Mahomed, H

Cytomegalovirus infection is a risk factor for TB disease in infants by Müller, J, Tanner, R, Matsumiya, M, Snowden, MA, Landry, B, Satti, I, Harris, SA, O'Shea, MK, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Thomas, Z-R, Stylianou, E, Naranbhai, V, Mbandi, SK, Hatherill, M, Hussey, G, Mahomed, H, Tameris, M, McClain, JB, Hanekom, WA, Evans, TG, Scriba, TJ, McShane, H

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants. by Fletcher, H, Snowden, M, Landry, B, Rida, W, Satti, I, Harris, S, Matsumiya, M, Tanner, R, O'Shea, M, Dheenadhayalan, V, Bogardus, L, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Manjaly Thomas, Z, Naranbhai, V, Stylianou, E, Darboe, F, Penn-Nicholson, A, Nemes, E, Hatheril, M, Hussey, G, Mahomed, H, Tameris, M, McClain, J, Evans, T, Hanekom, W, Scriba, T, McShane, H

T-cell activation is an immune correlate of risk in BCG vaccinated infants by Fletcher, H, Snowden, M, Landry, B, Rida, W, Satti, I, Harris, S, Matsumiya, M, Tanner, R, O'Shea, M, Dheenadhayalan, V, Bogardus, L, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Manjaly Thomas, Z, Naranbhai, V, Stylianou, E, Darboe, F, Penn-Nicholson, A, Nemes, E, Hatheril, M, Hussey, G, Mahomed, H, Tameris, M, McClain, J, Evans, T, Hanekom, W, Scriba, T, McShane, H